www.fdanews.com/articles/176823-respiratory-motion-gains-ce-mark-approval-for-exspiron
Respiratory Motion Gains CE Mark Approval for ExSpiron
May 26, 2016
WALTHAM, Mass.-based Respiratory Motion has received CE Mark approval to sell its minute ventilation monitor ExSpiron for tracking respiratory depression.
According to company CEO Jenny Freeman, ExSpiron is the only medical device able to provide this measurement in a patient monitor.
The device was introduced at the annual meeting of the Society of German Anesthesiologists last month. — Anisa Jibrell